Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01080521 : Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
AgesMin: 18 Years Max: N/A

- Histologically or pathologically confirmed primary diagnosis of stage I-IV ovarian,
primary peritoneal, or fallopian tube cancer (any cell type)

- Planning to receive ? 6 courses of front-line chemotherapy

- Have not yet received the first course of chemotherapy


- GOG performance status 0-2

- Able to read and understand English

- No uncontrolled or severe cardiovascular disease, including any of the following:

- Myocardial infarction within the past year

- Uncontrolled hypertension

- Congestive heart failure

- No history of head injury with GCS < 13

- No severe hemiparesis or other condition preventing bimanual keyboard operation

- No distal neuropathy, action tremor, or other motor dysfunction that would
substantially decrease keyboard accuracy

- No severe motor or mental slowing (i.e., patient who is disoriented/level C on any
criterion as assessed by the person-place-time criteria)

- No other invasive malignancies within the past 5 years except for nonmelanoma skin


- See Disease Characteristics

- No prior radiotherapy or chemotherapy

- More than 6 months since prior epoetin alfa, darbepoetin, or any investigational
forms of erythropoietin

- Patients may receive these agents during chemotherapy treatment as needed
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557